Siberians make cellular scaffolding to help organs grow, and grow fast
08 August 2017
Scientists at Tomsk Polytechnic (TPU) in Siberia have come up with a novel method of modifying polylactic-based biodegradable polymeric scaffolds, some sort of matrices that form the basis new organs and tissues would grow upon. The Siberian
Dermatology faces big changes, but pharma can help ease transition: expert
08 August 2017
Time for a pharma facelift—when it comes to dermatology, that is. In the new landscape of mega-practices and competing medi-spas, pharma can best help dermatologists by helping them show value, according to research from Ogilvy Commonhealth.
07 August 2017
Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, today announced completion of patient enrollment in the pivotal PEACHTREE clinical trial. This Phase 3 clinical trial is evaluating the safety and efficacy of CLS-TA for suprachoroidal administration (“suprachoroidal CLS-TA”), Clearside’s proprietary suspension formulation of the corticosteroid triamcinolone acetonide, for the treatment of macular edema associated with non-infectious uveitis. Patient follow-up in the PEACHTREE trial is 6 months. Accordingly, Clearside currently expects to report top-line results from the trial in the first quarter of 2018.
High marks to State Program for the Development of Russian Pharma Industry
07 August 2017
The Russian Ministry of Economic Development presented to the Government its consolidated report on the implementation and assessment of effectiveness of the state programs for 2016.
Big Pharma veterans at Pfizer, AstraZeneca join the great migration to biotech
07 August 2017
Biogen has recruited Anabella Villalobos as its new SVP of biotherapeutic & medicinal sciences. The neurosciences vet was poached from Pfizer, where she was head of medicinal synthesis technologies.
Doctors say pharma rep details are stale, need updating for digital age
04 August 2017
Despite the pharma sales force making great strides towards “digitizing the field” with tablets and other technologies – a new study from DRG Digital’s Manhattan Research finds that the content reps are showing in details is often old news. Physicians who see sales reps say that over half of the time (51%), the reps show them information they have already seen through their own research or in previous meetings.
Protons against cancer: new Russian discovery
04 August 2017
A team led by Svetlana Zaichkina of the Institute of Theoretical and Experimental Biophysics in Pushchino outside Moscow reportedly experimented with mice that had various cancers. The animals were exposed to proton radiation with a varying number of sessions, duration per session, and beam power.
What's powering pharma toward the next digital frontier? One expert has an idea
03 August 2017
If there’s one word that best describes what’s been driving pharma to adopt digital technology, it’s “access,” one expert says—and he expects that trend to continue.
Despite blockbuster boasts for R&D work, pressure increases on Pfizer to do a megadeal
02 August 2017
Some new products like Ibrance are gaining ground in the marketplace, helping Pfizer weather the storm of generic competition. But sales declined in Q2 as Prevnar revenue weakened and competition loomed for Viagra and Lyrica. And that will have analysts looking to see what CEO Ian Read will do next to right the course at the pharma giant; whether that’s big deals, new cost-cutting efforts, a company breakup, or a mix of all of the above.
New technology will make vaccines quality control in Russia 300 times faster
02 August 2017
National Immunobiological Company (Nacimbio) introduces a new technology to control the quality of anti-TB vaccines that cuts the period of procedure from one month to 1.5 hours. The technology is developed and tested in the Stavropol branch of NPO Microgen, a part of Nacimbio, and will increase the volume and speed of manufacturing BCG and BCG-M vaccines.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024